HC Wainwright & Co. reiterated coverage on Novan with a new price target

6/14/21 6:19:32 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Novan with a rating of Buy and set a new price target of $28.00 from $20.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$NOVN

Date	Price Target	Rating	Analyst
9/24/2021	$28.00 → $24.00	Buy	HC Wainwright & Co.
7/9/2021	$30.00	Overweight	Cantor Fitzgerald